Astel­las to close fa­cil­i­ty in Cal­i­for­nia; Take­da can make more of its AD­HD drug

Wel­come to End­points News’ man­u­fac­tur­ing briefs, where we bring you es­sen­tial news on new builds, col­lab­o­ra­tions, re­calls and more.

Astel­las Gene Ther­a­pies is shut­ter­ing its …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER